Finanza

Notizie Discussioni Tecnici Previsione Stagionalità

Totale passività e patrimonio netto su Acurx Pharmaceuticals, Inc..

Dati annuali

2020

2021

2022

2023

‪0,00‬

‪‪3,50 M‬‬

‪‪7,00 M‬‬

‪‪10,50 M‬‬

‪‪14,00 M‬‬

Periodo

Valore

Variazione

Variazione %

2023

‪‪7,71 M‬‬

‪‪−1,67 M‬‬

‪−17,78‬%

2022

‪‪9,38 M‬‬

‪‪−3,88 M‬‬

‪−29,25‬%

2021

‪‪13,25 M‬‬

+‪‪10,03 M‬‬

+‪311,11‬%

2020

‪‪3,22 M‬‬

+‪‪692,60 K‬‬

+‪27,36‬%

Dati trimestrali

Q2 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0,00‬

‪‪2,50 M‬‬

‪‪5,00 M‬‬

‪‪7,50 M‬‬

‪‪10,00 M‬‬

Periodo

Valore

Variazione

Variazione %

Q3 '24

‪‪5,98 M‬‬

‪‪−597,63 K‬‬

‪−9,08‬%

Q2 '24

‪‪6,58 M‬‬

‪‪−2,53 M‬‬

‪−27,76‬%

Q1 '24

‪‪9,11 M‬‬

+‪‪1,40 M‬‬

+‪18,16‬%

Q4 '23

‪‪7,71 M‬‬

+‪‪551,07 K‬‬

+‪7,70‬%

Q3 '23

‪‪7,16 M‬‬

‪‪−2,08 M‬‬

‪−22,50‬%

Q2 '23

‪‪9,24 M‬‬

+‪‪1,85 M‬‬

+‪25,05‬%

Q1 '23

‪‪7,39 M‬‬

‪‪−1,99 M‬‬

‪−21,24‬%

Q4 '22

‪‪9,38 M‬‬

‪‪−1,57 M‬‬

‪−14,33‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q2 '20